Researchers identify FGFR4, FLT1, and WNT5A as key biomarkers and suggest dovitinib and nintedanib as new targeted therapies ...
Neurological diseases now affect nearly half the world’s population, prompting global recognition and innovation as multiple ...
Self-administration of rozanolixizumab, a neonatal Fc receptor blocker (FcRn) indicated for generalized myasthenia gravis, ...
Andrew Wolf, MD, discusses the growing costs, treatment advances, and geographic disparities in multiple sclerosis care.
Abemaciclib plus endocrine therapy significantly improved overall survival, IDFS, and DRFS in HR-positive, HER2-negative, node-positive early breast cancer. Adjuvant abemaciclib (Verzenio; Eli Lilly) ...
Zongertinib received FDA approval for HER2-mutant NSCLC, showing efficacy in first-line treatment with a 77% objective ...
SGLT2 inhibitors may worsen heart failure outcomes from chemotherapy, highlighting the need for further long-term studies on ...
Disconnectome mapping provides a comprehensive understanding of how structural damage translates to cognitive dysfunction. Lesion-based disconnectome mapping suggests that the pattern, not the ...
A comprehensive, multi-phase investigation published in Advanced Science suggests that the amino acid tryptophan (Trp) may be a key determinant of therapeutic response to conventional synthetic ...
A birth control implant is available as a rod about the size of a matchstick that can release hormones into the body and prevent pregnancies for up to 5 years. 2,3 A doctor inserts it into the upper ...
Craig See, MD, a cornea specialist for the Cole Eye Institute at Cleveland Clinic, discussed alternatives to masks during Halloween as a means of better protecting eyes when dressing up for the season ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback